These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 15535129)
1. Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival. Surace EI; Lusis E; Murakami Y; Scheithauer BW; Perry A; Gutmann DH J Neuropathol Exp Neurol; 2004 Oct; 63(10):1015-27. PubMed ID: 15535129 [TBL] [Abstract][Full Text] [Related]
2. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas. Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976 [TBL] [Abstract][Full Text] [Related]
3. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719 [TBL] [Abstract][Full Text] [Related]
4. Mesothelin expression in the leptomeninges and meningiomas. Johnson MD; Vito F; O'Connell MJ J Histochem Cytochem; 2008 Jun; 56(6):579-85. PubMed ID: 18347077 [TBL] [Abstract][Full Text] [Related]
5. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival. Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286 [TBL] [Abstract][Full Text] [Related]
6. Cell-adhesion molecules in human meningiomas: correlation with clinical and morphological data. Figarella-Branger D; Roche PH; Daniel L; Dufour H; Bianco N; Pellissier JF Neuropathol Appl Neurobiol; 1997 Apr; 23(2):113-22. PubMed ID: 9160896 [TBL] [Abstract][Full Text] [Related]
7. Na-K-2Cl cotransporter and aquaporin 1 in arachnoid granulations, meningiomas, and meningiomas invading dura. Johnson MD; O'Connell M Hum Pathol; 2013 Jun; 44(6):1118-24. PubMed ID: 23317544 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas. Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125 [TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma. van de Nes JA; Griewank KG; Schmid KW; Grabellus F Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354 [TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma. Liu D; Feng X; Wu X; Li Z; Wang W; Tao Y; Xia Y Tumour Biol; 2013 Dec; 34(6):3773-83. PubMed ID: 23812766 [TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway. Johnson MD; O'Connell MJ; Vito F; Pilcher W J Neuropathol Exp Neurol; 2009 Nov; 68(11):1177-83. PubMed ID: 19816200 [TBL] [Abstract][Full Text] [Related]
13. CIP2A and PP2A in human leptomeninges, arachnoid granulations and meningiomas. Johnson MD; Reeder JE; O'Connell M; Woodford M; Walter K J Clin Neurosci; 2014 Dec; 21(12):2228-32. PubMed ID: 25012485 [TBL] [Abstract][Full Text] [Related]
14. Expression of the TSLC1 adhesion molecule in pulmonary epithelium and its down-regulation in pulmonary adenocarcinoma other than bronchioloalveolar carcinoma. Ito A; Okada M; Uchino K; Wakayama T; Koma Y; Iseki S; Tsubota N; Okita Y; Kitamura Y Lab Invest; 2003 Aug; 83(8):1175-83. PubMed ID: 12920246 [TBL] [Abstract][Full Text] [Related]
15. Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. Kalamarides M; Stemmer-Rachamimov AO; Takahashi M; Han ZY; Chareyre F; Niwa-Kawakita M; Black PM; Carroll RS; Giovannini M Brain Pathol; 2008 Jan; 18(1):62-70. PubMed ID: 17924978 [TBL] [Abstract][Full Text] [Related]
16. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Gutmann DH; Donahoe J; Perry A; Lemke N; Gorse K; Kittiniyom K; Rempel SA; Gutierrez JA; Newsham IF Hum Mol Genet; 2000 Jun; 9(10):1495-500. PubMed ID: 10888600 [TBL] [Abstract][Full Text] [Related]
17. Comparative proteomic profiles of meningioma subtypes. Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085 [TBL] [Abstract][Full Text] [Related]
18. Altered expression of beta-catenin/E-cadherin in meningiomas. Brunner EC; Romeike BF; Jung M; Comtesse N; Meese E Histopathology; 2006 Aug; 49(2):178-87. PubMed ID: 16879395 [TBL] [Abstract][Full Text] [Related]
20. [Expressions and clinical significances of TSLC1 and 4.1B in non-small cell lung cancer]. Wang Z; Yang K; Wang X; Zhang J; Hao D; Chen Z Zhongguo Fei Ai Za Zhi; 2010 Nov; 13(11):1041-5. PubMed ID: 21081044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]